Genes in MS Patients Yorktown Heights NY

Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports. "Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release.

Local Companies

Dawn Weiner
(845) 279-2000
666 Stoneleigh Avenue
Carmel, NY
Jeffrey Gershel
(914) 666-4742
666 Lexington Ave Ste 107
Mount Kisco, NY
Milton Kemp
(516) 487-2190
748 Heritage Hls
Somers, NY
Rubin Cheryl
(845) 356-2900
18 College Road
Monsey, NY
Eric Oberman
(845) 359-0010
422 Western Hwy
Tappan, NY
Richard Charles Connors
(203) 622-0808
1 Perryridge Road
Greenwich, CT
Nanette Santoro
(914) 997-1060
141 S Central Park Ave
Hartsdale, NY
Myung-Ho Lee
(914) 251-4799
62 Bowman Avenue
Port Chester, NY
Gerald Campana
(914) 946-0050
222 Mamaroneck Avenue
White Plains, NY
Elliot Siegal
(845) 623-8500
259 North Middletown Road
Nanuet, NY
Data Provided by:
  

Provided By:

FRIDAY, Sept. 11 (HealthDay News) -- Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports.

"Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release. "This study asked, among those who have MS, why do some do well with the disease while others do poorly, and what might be the genetic determinants of this difference in outcome."

The study, which was scheduled to be presented Friday at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, Germany, identified two genes that appear to lead to repair of damage caused by multiple sclerosis in mice.

Multiple sclerosis affects about 330,000 people in the United States. The disease targets the central nervous system and damages the insulation that covers nerves. People with the disease suffer from a variety of symptoms, including loss of strength, vision, balance and muscle coordination.

"It's possible that the identification of these genes may provide the first important clue as to why some patients with MS do well, while others do not," Bieber said in the news release.

More information

Learn more about the disease from the National Multiple Sclerosis Society.

SOURCE: Mayo clinic, news release, Sept. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com